{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:05:57Z","timestamp":1776081957135,"version":"3.50.1"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.neuroscience.2025.07.001","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T11:58:41Z","timestamp":1751457521000},"page":"50-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Evaluation of potential biomarker miRNAs and the levels of serotonin and dopamine in female patients with obsessive\u2013compulsive disorder"],"prefix":"10.1016","volume":"581","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1173-1701","authenticated-orcid":false,"given":"Nur Damla","family":"Korkmaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9462-0862","authenticated-orcid":false,"given":"Birsen","family":"Elibol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeynep","family":"Durmus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6357-3257","authenticated-orcid":false,"given":"Abdullah","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahri","family":"Akbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6626-1874","authenticated-orcid":false,"given":"Sinan","family":"Guloksuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cigdem Dilek","family":"Sahbaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2025.07.001_b0005","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.biopsych.2009.03.012","article-title":"The serotonin-1A receptor in anxiety disorders","volume":"66","author":"Akimova","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0010","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2174\/1570159X16666180620155941","article-title":"Suicide risk in obsessive-compulsive disorder and exploration of risk factors: a systematic review","volume":"17","author":"Albert","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0015","series-title":"Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)","year":"1994"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0020","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/jamapsychiatry.2017.1567","article-title":"Inflammation in the neurocircuitry of obsessive-compulsive disorder","volume":"74","author":"Attwells","year":"2017","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1478-811X-12-30","article-title":"Good guy or bad guy: the opposing roles of microRNA 125b in cancer","volume":"12","author":"Banzhaf-Strathmann","year":"2014","journal-title":"Cell Commun. Signaling"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0030","series-title":"Clinical handbook of psychological disorders: a step-by-step treatment manual","author":"Barlow","year":"2021"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.comppsych.2017.04.002","article-title":"Comorbidity, age of onset and suicidality in obsessive-compulsive disorder (OCD): an international collaboration","volume":"76","author":"Brakoulias","year":"2017","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0040","doi-asserted-by":"crossref","first-page":"313","DOI":"10.9758\/cpn.2017.15.4.313","article-title":"Peripheral Signatures of Psychiatric Disorders: MicroRNAs","volume":"15","author":"Camkurt","year":"2017","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0045","first-page":"1","article-title":"Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]","volume":"5","author":"Carey","year":"2005","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.schres.2018.07.030","article-title":"Identification of a miRNAs signature associated with exposure to stress early in life and enhanced vulnerability for schizophrenia: New insights for the key role of miR-125b-1-3p in neurodevelopmental processes","volume":"205","author":"Cattane","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0055","doi-asserted-by":"crossref","first-page":"D127","DOI":"10.1093\/nar\/gkz757","article-title":"miRDB: an online database for prediction of functional microRNA targets","volume":"48","author":"Chen","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0060","first-page":"11","article-title":"The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence","volume":"65","author":"Denys","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ajmg.b.30149","article-title":"A family study of early-onset obsessive-compulsive disorder","volume":"136B","author":"do Rosario-Campos","year":"2005","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0070","first-page":"783","article-title":"Obsessive-compulsive disorder. CONTINUUM: Lifelong Learning","volume":"21","author":"Drubach","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0075","doi-asserted-by":"crossref","first-page":"43","DOI":"10.31887\/DCNS.2014.16.1\/ydwivedi","article-title":"Emerging role of microRNAs in major depressive disorder: diagnosis and therapeutic implications","volume":"16","author":"Dwivedi","year":"2014","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0080","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neuron.2010.01.005","article-title":"Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132","volume":"65","author":"Edbauer","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1193053","article-title":"Roles of microglia in adult hippocampal neurogenesis in depression and their therapeutics","volume":"14","author":"Fang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0090","article-title":"Stress Influences the effect of Obsessive-Compulsive Symptoms on Emotion Regulation","volume":"11","author":"Ferreira","year":"2020","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fnmol.2014.00005","article-title":"MicroRNAs in brain development and function: a matter of flexibility and stability","volume":"7","author":"Follert","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.biopsych.2014.12.009","article-title":"MicroRNA and posttranscriptional dysregulation in psychiatry","volume":"78","author":"Geaghan","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0105","first-page":"25","article-title":"Sex-Biased Expression and Response of microRNAs in Neurological Diseases and Neurotrauma","author":"Geleta","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0110","unstructured":"Goodman WK, McDougle CJ, Price LH, Riddle MA, Pauls D, Leckman J (1990), Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? The Journal of clinical psychiatry 51:36-43; discussion 55."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0115","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0120","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neubiorev.2018.01.016","article-title":"Frontoparietal areas link impairments of large-scale intrinsic brain networks with aberrant fronto-striatal interactions in OCD: a meta-analysis of resting-state functional connectivity","volume":"87","author":"Gursel","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0125","doi-asserted-by":"crossref","first-page":"e862","DOI":"10.1038\/tp.2016.131","article-title":"MicroRNAs as biomarkers for major depression: a role for let-7b and let-7c","volume":"6","author":"Gururajan","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0130","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/2047-783X-14-8-367","article-title":"Maintenance electroconvulsive therapy for comorbid pharmacotherapy-refractory obsessive-compulsive and schizoaffective disorder","volume":"14","author":"Hanisch","year":"2009","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0135","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/0006-3223(91)90193-P","article-title":"Whole blood serotonin in juvenile obsessive-compulsive disorder","volume":"29","author":"Hanna","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015497","article-title":"Transgenic miR132 alters neuronal spine density and impairs novel object recognition memory","volume":"5","author":"Hansen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0145","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0006-3223(00)00956-2","article-title":"Reactivity of serotonin in whole blood: relationship with drug response in obsessive-compulsive disorder","volume":"49","author":"Humble","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0150","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrn3879","article-title":"Determining the role of microRNAs in psychiatric disorders","volume":"16","author":"Issler","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0155","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s12031-023-02161-8","article-title":"Investigation of LncRNA PVT1 and MiR-21-5p Expression as Promising Novel Biomarkers for Autism Spectrum Disorder","volume":"73","author":"Jiang","year":"2023","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0160","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/nn2010","article-title":"Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA","volume":"10","author":"Klein","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0165","doi-asserted-by":"crossref","first-page":"e717","DOI":"10.1038\/tp.2015.213","article-title":"Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue","volume":"6","author":"Lai","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0170","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148853","article-title":"MicroRNA-26a-3p rescues depression-like behaviors in male rats via preventing hippocampal neuronal anomalies","volume":"131","author":"Li","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0175","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.gpb.2012.07.005","article-title":"MicroRNAs in common human diseases","volume":"10","author":"Li","year":"2012","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0180","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/B978-0-444-53497-2.00019-X","article-title":"Deep brain stimulation in obsessive-compulsive disorder: neurocircuitry and clinical experience","volume":"116","author":"Lipsman","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0185","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/B978-0-444-53497-2.00019-X","article-title":"Deep brain stimulation in obsessive\u2013compulsive disorder: neurocircuitry and clinical experience","volume":"116","author":"Lipsman","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0190","first-page":"5","article-title":"Practice guideline for the treatment of patients with obsessive-compulsive disorder","volume":"164","author":"Lm k","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0195","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jad.2016.04.021","article-title":"Peripheral whole blood microRNA alterations in major depression and bipolar disorder","volume":"200","author":"Maffioletti","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0200","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.biopsych.2020.01.006","article-title":"Maternal Effects as Causes of risk for Obsessive-Compulsive Disorder","volume":"87","author":"Mahjani","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0205","doi-asserted-by":"crossref","first-page":"41127","DOI":"10.1038\/srep41127","article-title":"Selection of reference genes is critical for miRNA expression analysis in human cardiac tissue. a focus on atrial fibrillation","volume":"7","author":"Mase","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0210","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1590\/S1516-44462011000400014","article-title":"Gender differences in obsessive-compulsive disorder: a literature review","volume":"33","author":"Mathis","year":"2011","journal-title":"Braz J Psychiatry"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0215","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1602\/neurorx.1.2.182","article-title":"Biomarkers: potential uses and limitations","volume":"1","author":"Mayeux","year":"2004","journal-title":"NeuroRx"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0220","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/jamapsychiatry.2015.3105","article-title":"Mortality among persons with obsessive-compulsive disorder in Denmark","volume":"73","author":"Meier","year":"2016","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0225","doi-asserted-by":"crossref","first-page":"39782","DOI":"10.1038\/srep39782","article-title":"Validation of suitable normalizers for miR expression patterns analysis covering tumour heterogeneity","volume":"7","author":"Morata-Tarifa","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0230","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/humu.21005","article-title":"Allele variants in functional microRNA target sites of the neurotrophin\u20103 receptor gene (NTRK3) as susceptibility factors for anxiety disorders","volume":"30","author":"Mui\u00f1os-Gimeno","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0235","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2012.0435","article-title":"Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity","volume":"368","author":"Murphy","year":"2013","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0240","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.psc.2009.11.001","article-title":"Genetics of obsessive-compulsive disorder","volume":"33","author":"Nestadt","year":"2010","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0245","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00213-020-05758-8","article-title":"Serotonin 5-HT(1B) receptor-mediated behavior and binding in mice with the overactive and dysregulated serotonin transporter Ala56 variant","volume":"238","author":"O'Reilly","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0250","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1517\/14728214.2014.875157","article-title":"Emerging drugs to treat obsessive\u2013compulsive disorder","volume":"19","author":"Pallanti","year":"2014","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0255","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.pnpbp.2005.11.028","article-title":"Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines","volume":"30","author":"Pallanti","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0260","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrn3746","article-title":"Obsessive\u2013compulsive disorder: an integrative genetic and neurobiological perspective","volume":"15","author":"Pauls","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0265","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5152\/pcp.2022.22391","article-title":"Can miRNA Expression Levels Predict Treatment Resistance to Serotonin Reuptake Inhibitors in patients with Obsessive-Compulsive Disorder?","volume":"32","author":"Pirdogan Aydin","year":"2022","journal-title":"Psychiatry Clin. Psychopharmacol."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0270","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.pharmthera.2011.09.006","article-title":"Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment","volume":"132","author":"Pittenger","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0275","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3389\/fphar.2017.00770","article-title":"Advances in roles of miR-132 in the nervous system","volume":"8","author":"Qian","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093031","article-title":"An extended \u0394CT-method facilitating normalisation with multiple reference genes suited for quantitative RT-PCR analyses of human hepatocyte-like cells","volume":"9","author":"Riedel","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0285","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0377-1237(09)80120-2","article-title":"Serum Serotonin Abnormality in Depression","volume":"65","author":"Saldanha","year":"2009","journal-title":"Med. J. Armed Forces India"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0290","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1037\/bul0000102","article-title":"Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms","volume":"143","author":"Salk","year":"2017","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0295","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0893-133X(99)00082-2","article-title":"Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder","volume":"21","author":"Saxena","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0300","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20071546","article-title":"Human Brain Injury and miRNAs: an Experimental Study","volume":"20","author":"Sessa","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0305","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.pnpbp.2017.06.037","article-title":"Quantifying dimensional severity of obsessive-compulsive disorder for neurobiological research","volume":"79","author":"Shavitt","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0310","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ni.1828","article-title":"Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21","volume":"11","author":"Sheedy","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0315","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.euroneuro.2023.07.012","article-title":"Biological markers of sex-based differences in major depressive disorder and in antidepressant response","volume":"76","author":"Silva","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0320","series-title":"Stahl's essential psychopharmacology: neuroscientific basis and practical applications","author":"Stahl","year":"2021"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0325","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-019-0102-3","article-title":"Obsessive\u2013compulsive disorder","volume":"5","author":"Stein","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0330","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1320650","article-title":"GDNF and miRNA-29a as biomarkers in the first episode of psychosis: uncovering associations with psychosocial factors","volume":"15","author":"Szwajca","year":"2024","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0335","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbr.2016.07.004","article-title":"Cortico-striato-thalamo-cortical circuit abnormalities in obsessive-compulsive disorder: a voxel-based morphometric and fMRI study of the whole brain","volume":"313","author":"Tang","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0340","first-page":"179","article-title":"Agomelatine augmentation in obsessive compulsive disorder: a preliminary report","volume":"25","author":"Tzavellas","year":"2014","journal-title":"Psychiatriki"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0345","article-title":"Micro-RNAs from Plasma-Derived Small Extracellular Vesicles as potential Biomarkers for Tic Disorders Diagnosis","volume":"12","author":"Wang","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0350","doi-asserted-by":"crossref","first-page":"9093","DOI":"10.1073\/pnas.0803072105","article-title":"An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP","volume":"105","author":"Wayman","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0355","doi-asserted-by":"crossref","first-page":"7112","DOI":"10.1038\/s41598-018-25554-x","article-title":"Stress-associated changes in salivary microRNAs can be detected in response to the Trier Social stress Test: an exploratory study","volume":"8","author":"Wiegand","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0360","doi-asserted-by":"crossref","unstructured":"Yue J, Zhang B, Wang H, Hou X, Chen X, Cheng M, Wen S (2020), Dysregulated plasma levels of miRNA-132 and miRNA-134 in patients with obsessive-compulsive disorder. Annals of Translational Medicine 8.","DOI":"10.21037\/atm-20-5217"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0365","doi-asserted-by":"crossref","first-page":"996","DOI":"10.21037\/atm-20-5217","article-title":"Dysregulated plasma levels of miRNA-132 and miRNA-134 in patients with obsessive-compulsive disorder","volume":"8","author":"Yue","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.neuroscience.2025.07.001_b0370","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12035-013-8595-3","article-title":"Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer's disease (AD) and in primary human neuronal-glial (HNG) cells","volume":"50","author":"Zhao","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2025.07.001_b0375","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1038\/npp.2008.35","article-title":"Changes in thalamus\u2013hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive\u2013compulsive disorder","volume":"33","author":"Zitterl","year":"2008","journal-title":"Neuropsychopharmacology"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645222500764X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645222500764X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T12:09:12Z","timestamp":1753790952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030645222500764X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":75,"alternative-id":["S030645222500764X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.07.001","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of potential biomarker miRNAs and the levels of serotonin and dopamine in female patients with obsessive\u2013compulsive disorder","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}